# The Clinical and Economic Impact of Penicillin Allergy

> **NIH NIH K01** · MASSACHUSETTS GENERAL HOSPITAL · 2020 · $137,160

## Abstract

Project Summary
Candidate Kimberly G. Blumenthal, MD is an Assistant in Medicine in the Allergy and Clinical Immunology Unit
at Massachusetts General Hospital (MGH) and an Instructor of Medicine at Harvard Medical School (HMS).
After her undergraduate training in economics at Columbia University and the London School of Economics,
she received her M.D. from Yale University. Dr. Blumenthal began working with Rochelle P. Walensky, MD,
MPH and the Medical Practice Evaluation Center (MPEC) at MGH after completion of her clinical training at
MGH in Internal Medicine and Allergy/Immunology. Dr. Blumenthal studies drug allergy epidemiology and
impact on patient care; she has authored 13 total manuscripts, with 7 first-authored peer-reviewed
manuscripts, including publications in the Journal of Allergy and Clinical Immunology and Clinical Infectious
Diseases. Dr. Blumenthal is completing a Masters of Science in Epidemiology at the Harvard T.H. Chan
School of Public Health. Dr. Blumenthal's goal is to become a national leader in drug allergy with methods
expertise in clinical epidemiology and decision science.
Mentorship, Training Activities, and Environment Dr. Blumenthal will perform the work outlined in this
proposal at MGH under the mentorship of Rochelle P. Walensky, MD, MPH and co-mentorship of Aleena
Banerji, MD. Dr. Walensky, Co-director of MPEC, is a nationally-recognized expert in decision science whose
research has motivated national and international policies related to testing and treatment of Human
Immunodeficiency Virus. Dr. Walensky has been NIH-funded since 2006; she has served as a mentor to over 5
prior K awardees, and has successfully transitioned fellows to independent R01-funded research careers. Dr.
Banerji is a nationally-recognized expert in drug allergy with expertise in epidemiology and outcomes research.
Dr. Blumenthal's research will benefit from the specific expertise of collaborators: Carlos A. Camargo, MD,
DrPH (epidemiology), Robert A. Parker, ScD (biostatistics), Stephen Resch, PhD (resource utilization), Li
Zhou, MD, PhD (bioinformatics) and Erica S. Shenoy, MD, PhD (infection control). Dr. Blumenthal has
organized a Scientific Advisory Board, chaired by Dr. Camargo, that includes: Andrew D. Luster, MD, PhD,
Katrina A. Armstrong, MD, MSCE and David W. Bates, MD, MSc. To complement the expertise of her mentors,
collaborators and advisors, Dr. Blumenthal will complete didactic courses to acquire new research skills,
including linkage and analysis of large databases, resource utilization analysis and simulation modeling and
cost-effectiveness analysis. The collaborative opportunities, intellectual environment, and resources available
to Dr. Blumenthal are outstanding and will provide her with a clear path to independent research success.
Research Penicillin (PCN) allergy is reported by over 10% of the U.S. population, though a self-reported PCN
allergy infrequently reflects an actual inability to tolerate PCNs and other β-l...

## Key facts

- **NIH application ID:** 9921287
- **Project number:** 5K01AI125631-05
- **Recipient organization:** MASSACHUSETTS GENERAL HOSPITAL
- **Principal Investigator:** Kimberly G. Blumenthal
- **Activity code:** K01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $137,160
- **Award type:** 5
- **Project period:** 2016-06-22 → 2021-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9921287

## Citation

> US National Institutes of Health, RePORTER application 9921287, The Clinical and Economic Impact of Penicillin Allergy (5K01AI125631-05). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/9921287. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*